Brief: Celsion Corporation Highlights Progress In DNA-Based Vaccine Program

Sept 1 (Reuters) - Celsion Corp  CLSN.O :
    * CELSION CORPORATION HIGHLIGHTS PROGRESS IN ITS DNA-BASED
VACCINE
PROGRAM

Source text for Eikon:  ID:nGNXbDS0kt 
Further company coverage:  CLSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Imunon

See all news